Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Jill Henricksen |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Psychotherapy of obsessive-compulsive disorder and spectrum / Fugen Neziroglu en Psychiatric Clinics of North America, Año 2006 - Vol. 29 No. 2 (Junio)
[artículo]
Título : Psychotherapy of obsessive-compulsive disorder and spectrum : established facts and advances, 1995–2005 Tipo de documento: texto impreso Autores: Fugen Neziroglu, Autor ; Jill Henricksen, Autor ; Jose A. Yaryura-Tobias, Autor Fecha de publicación: 2020 Artículo en la página: pp. 585-604 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Terapia cognitivo-conductual, Terapia de modalidad combinada, Trastorno obsesivo-compulsivo. Resumen: Dropout rates and refractory cases persist, for reasons that remain unexplained. There are few predictor variables and few innovative approaches to deal with them. New treatment approaches must be developed to improve treatment response even for the responders. Studies show that symptoms are reduced minimally (30% 50%). No new ways of dealing with treatment-refractory cases have been developed. Link: ./index.php?lvl=notice_display&id=24615
in Psychiatric Clinics of North America > Año 2006 - Vol. 29 No. 2 (Junio) . - pp. 585-604[artículo] Psychotherapy of obsessive-compulsive disorder and spectrum : established facts and advances, 1995–2005 [texto impreso] / Fugen Neziroglu, Autor ; Jill Henricksen, Autor ; Jose A. Yaryura-Tobias, Autor . - 2020 . - pp. 585-604.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Psychiatric Clinics of North America > Año 2006 - Vol. 29 No. 2 (Junio) . - pp. 585-604
Palabras clave: Terapia cognitivo-conductual, Terapia de modalidad combinada, Trastorno obsesivo-compulsivo. Resumen: Dropout rates and refractory cases persist, for reasons that remain unexplained. There are few predictor variables and few innovative approaches to deal with them. New treatment approaches must be developed to improve treatment response even for the responders. Studies show that symptoms are reduced minimally (30% 50%). No new ways of dealing with treatment-refractory cases have been developed. Link: ./index.php?lvl=notice_display&id=24615